Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-006837
Date:2020-05-29
Issuer: ABIOMED INC (ABMD)
Original Submission Date:

Reporting Person:

WEBER DAVID M
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE DANVERS, MA 01923

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $.01 PAR VALUE 2020-05-29 A 3,033 a $0.00 124,932 direct
COMMON STOCK, $.01 PAR VALUE 2020-05-29 0 $0.00 15,497 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 223.9 2020-05-29 deemed execution date A 5,000 (a) 2021-05-29 2030-05-29 common stock 5,000 $223.90 5,000 direct
STOCK OPTION (RIGHT TO BUY) 23.15 2020-05-29 deemed execution date 0 ( ) 2014-05-14 2023-05-14 common stock 0 $23.15 13,000 direct
STOCK OPTION (RIGHT TO BUY) 21.55 2020-05-29 deemed execution date 0 ( ) 2015-05-14 2024-05-14 common stock 0 $21.55 10,825 direct
STOCK OPTION (RIGHT TO BUY) 66.25 2020-05-29 deemed execution date 0 ( ) 2016-05-13 2025-05-13 common stock 0 $66.25 10,000 direct
STOCK OPTION (RIGHT TO BUY) 99.62 2020-05-29 deemed execution date 0 ( ) 2017-05-24 2026-05-24 common stock 0 $99.62 7,000 direct
STOCK OPTION (RIGHT TO BUY) 134.51 2020-05-29 deemed execution date 0 ( ) 2018-05-15 2027-05-15 common stock 0 $134.51 8,000 direct
STOCK OPTION (RIGHT TO BUY) 381.97 2020-05-29 deemed execution date 0 ( ) 2019-05-16 2028-05-16 common stock 0 $381.97 6,500 direct
STOCK OPTION (RIGHT TO BUY) 266.39 2020-05-29 deemed execution date 0 ( ) 2020-05-30 2029-05-30 common stock 0 $266.39 6,000 direct
Footnotes
IDfootnote
f1 this option becomes exercisable in annual 25% increments, commencing on the date shown in table ii, column 6.
f2 grant to reporting person of option to buy the number of shares of common stock set forth in table ii, column 7, under the abiomed, inc. 2008 stock incentive plan.
f3 these options become exercisable in annual 33-1/3% increments, commencing on the date shown in table ii, column 6.
f4 grant to reporting person of option to buy the number of shares of common stock set forth in table ii, column 7, under the abiomed, inc. 2015 omnibus incentive plan.
f5 consists of restricted stock units granted to the reporting person. one third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of may 29, 2021, may 29, 2022 and may 29, 2023, so long as the reporting person continues to be employed by the issuer on the vesting dates.
WhaleWisdom Logo

Elevate your investments